Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Journal of Personalized Medicine|February 25, 2023
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor ResectionBarbara Altieri, Anna La Salvia, Roberta Modica, et al.
The Journal of Clinical Endocrinology and Metabolism|August 17, 2018
Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized PrognosticationJuliane Lippert, Silke Appenzeller, Raimunde Liang, et al.
Frontiers in Endocrinology|December 15, 2023
PPARG dysregulation as a potential molecular target in adrenal Cushing's syndromeSharmilee Vetrivel, Mariangela Tamburello, Andrea Oßwald, et al.
Nature Communications|January 3, 2025
SOX2+ sustentacular cells are stem cells of the postnatal adrenal medullaAlice Santambrogio, Yasmine Kemkem, Thea L Willis, et al.
Endocrine|May 30, 2020
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspectiveGiovanna Muscogiuri, Barbara Altieri, Manuela Albertelli, et al.
Endocrine|July 31, 2025
Metabolic phenotype in non-aldosterone producing adrenal adenomas with co-existent polycystic ovary syndrome: a joint Ens@t projectAriadni Spyroglou, Panagiota Konstantakou, Marianna Minnetti, et al.
Journal of Personalized Medicine|April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered QuestionVittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 31, 2018
AN ITALIAN SURVEY OF COMPLIANCE WITH MAJOR GUIDELINES FOR L-THYROXINE OF PRIMARY HYPOTHYROIDISMSilvia Vezzani, Elisa Giannetta, Barbara Altieri, et al.
Journal of Clinical Medicine|November 6, 2019
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant TreatmentSoraya Puglisi, Anna Calabrese, Vittoria Basile, et al.
European Journal of Endocrinology|June 26, 2025
Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15: impact on poor prognosis and impaired responsiveness to immunotherapyIsabel Weigand, Alexandra S Triebig, Tanja Maier, et al.
Pageof 12